TIPQC - Medication Assisted Treatment of Opioid Use Disorder: A Patients Perspective-CME



Wednesday, December 2, 2020, 12:01 PM - Friday, December 2, 2022, 11:59 PM


Specialties - Emergency Medicine, Health Policy, Medicine, Nursing, Obstetrics and Gynecology, Pediatrics, Pharmacology, Pharmacy, Psychiatry and Behavioral Sciences, Social Work


AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Attendance (0.50 hours)


Educational module in which a subject matter expert discusses with a patient the need and benefits of medication assisted treatment (MAT) for opioid use disorders (OUD) and facts that refute biases and stigma associated with MAT and OUD.



Objectives
At the conclusion of this educational activity, participants should be able to:

  1. Describe and discuss biases and stigma associated with medication assisted treatment for opioid use disorders.
  2. Describe and discuss the benefits and needs of medication assisted treatment for opioid use disorders.
  3. Describe and discuss a patients perspective on the benefits and needs of medication assisted treatment for opioid use disorders.
  4. Describe and discuss the support healthcare providers should provide for mothers receiving medication assisted treatment for opioid use disorders.


Vanderbilt University Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vanderbilt University Medical Center designates this live activity for a maximum 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.